For both cohorts, baseline characteristic included liver damage (plasma ALT levels, degree of fibrosis and/or steatosis in the liver biopsy) and viral replication markers (plasma levels of HBsAg or plasma and liver HBV-DNA levels, or percentage of HBsAg positively stained cells in the liver biopsy). This evidence concerns the gene GPT and steatosis.